Showing posts with label Ponesimod. Show all posts
Showing posts with label Ponesimod. Show all posts

Linaclotide, Teriflunomide and Ponesimod - Comprehensive patent search

on Friday, 19 June 2015
ALBANY, NY, June 2015 -- ResearchMoz.us includes new market research report " Linaclotide, Teriflunomide and Ponesimod - Comprehensive patent search " to its huge collection of research reports.

Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface. 

Recent Release - Ponesimod, Siponimod and Sofosbuvir - Key patent, SPC, and data exclusivity expiry (44 country coverage)

ALBANY, NY, June 2015 -- ResearchMoz.us includes new market research report " Ponesimod, Siponimod and Sofosbuvir - Key patent, SPC, and data exclusivity expiry (44 country coverage) " to its huge collection of research reports.

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players.